Cite this DOI
10.46243/jst.2021.v6.i2.pp17-22 · Distinctiveness of Nanoparticles Drug Delivery in Cancer
APA (7th edition)
Sikkander, D. M., Kavitha, D., Sasikala, M. S., & Yasmeen, D. (2021). Distinctiveness of Nanoparticles Drug Delivery in Cancer. *Journal of Science & Technology*, *06*(02), 17–22. https://doi.org/10.46243/jst.2021.v6.i2.pp17-22
⬇ text Italics are shown as *asterisks* in plain text — the journal or book title and the volume.
BibTeX
@article{sikkander2021distinctiveness,
author = {Sikkander, Dr.A. Mohamed and Kavitha, Dr.K and Sasikala, Ms. S and Yasmeen, Dr.Khadeeja},
title = {{Distinctiveness of Nanoparticles Drug Delivery in Cancer}},
journal = {Journal of Science \& Technology},
year = {2021},
month = {feb},
volume = {06},
number = {02},
pages = {17--22},
publisher = {Longman Publishers},
issn = {2456-5660},
doi = {10.46243/jst.2021.v6.i2.pp17-22},
url = {https://doi.org/10.46243/jst.2021.v6.i2.pp17-22},
language = {en},
abstract = {Nanomedicine is the effect of advances in Nanoscience and nanotechnology and is normally referred to as biotechnology applications in Nanoscience and nanotechnology. Also, the Nanomedicine development of fields of analysis and treatment in biological systems at the cellular and sub-cellular levels has provided revolutionary methods for the recognition and deterrence of certain fatal diseases. For example, the National Cancer Institute of America expects nanotechnology and Nanoscience to be used to manage cancer and thus reduce mortality. Because of the closeness of Nanoscience to fertility, the US Department of the Food and Drug direction has been exploring the complex issues associated with nanoscale testing, nanoparticles, and Nanosystems to get better human life. Nanoscale resources can be described as a range of atoms up to 100 nanometers, and almost a nanoscale substance is defined as a material with the smallest dimensions of less than 100 nanometers.}
}RIS (EndNote, Zotero, Mendeley)
TY - JOUR TI - Distinctiveness of Nanoparticles Drug Delivery in Cancer AU - Sikkander, Dr.A. Mohamed AU - Kavitha, Dr.K AU - Sasikala, Ms. S AU - Yasmeen, Dr.Khadeeja JO - Journal of Science & Technology PY - 2021 DA - 2021/02/03/ VL - 06 IS - 02 SP - 17 EP - 22 PB - Longman Publishers SN - 2456-5660 LA - en AB - Nanomedicine is the effect of advances in Nanoscience and nanotechnology and is normally referred to as biotechnology applications in Nanoscience and nanotechnology. Also, the Nanomedicine development of fields of analysis and treatment in biological systems at the cellular and sub-cellular levels has provided revolutionary methods for the recognition and deterrence of certain fatal diseases. For example, the National Cancer Institute of America expects nanotechnology and Nanoscience to be used to manage cancer and thus reduce mortality. Because of the closeness of Nanoscience to fertility, the US Department of the Food and Drug direction has been exploring the complex issues associated with nanoscale testing, nanoparticles, and Nanosystems to get better human life. Nanoscale resources can be described as a range of atoms up to 100 nanometers, and almost a nanoscale substance is defined as a material with the smallest dimensions of less than 100 nanometers. DO - 10.46243/jst.2021.v6.i2.pp17-22 UR - https://doi.org/10.46243/jst.2021.v6.i2.pp17-22 ER -
CSL-JSON
{
"type": "article-journal",
"id": "10.46243/jst.2021.v6.i2.pp17-22",
"DOI": "10.46243/jst.2021.v6.i2.pp17-22",
"URL": "https://doi.org/10.46243/jst.2021.v6.i2.pp17-22",
"title": "Distinctiveness of Nanoparticles Drug Delivery in Cancer",
"source": "Smart Scholars DOI Registry",
"container-title": "Journal of Science & Technology",
"author": [
{
"family": "Sikkander",
"given": "Dr.A. Mohamed",
"ORCID": "https://orcid.org/0000-0002-8458-7448"
},
{
"family": "Kavitha",
"given": "Dr.K"
},
{
"family": "Sasikala",
"given": "Ms. S"
},
{
"family": "Yasmeen",
"given": "Dr.Khadeeja"
}
],
"issued": {
"date-parts": [
[
2021,
2,
3
]
]
},
"volume": "06",
"issue": "02",
"page": "17-22",
"publisher": "Longman Publishers",
"language": "en",
"abstract": "Nanomedicine is the effect of advances in Nanoscience and nanotechnology and is normally referred to as biotechnology applications in Nanoscience and nanotechnology. Also, the Nanomedicine development of fields of analysis and treatment in biological systems at the cellular and sub-cellular levels has provided revolutionary methods for the recognition and deterrence of certain fatal diseases. For example, the National Cancer Institute of America expects nanotechnology and Nanoscience to be used to manage cancer and thus reduce mortality. Because of the closeness of Nanoscience to fertility, the US Department of the Food and Drug direction has been exploring the complex issues associated with nanoscale testing, nanoparticles, and Nanosystems to get better human life. Nanoscale resources can be described as a range of atoms up to 100 nanometers, and almost a nanoscale substance is defined as a material with the smallest dimensions of less than 100 nanometers.",
"ISSN": "2456-5660"
} ⬇ .json What citeproc and reference managers read; the DOI system hands it out for Accept: application/vnd.citationstyles.csl+json, and so does this registry's resolver.
From the record as registered (version 2) — the record and its history. Programs: https://registry.smartscholars.in/api.php?action=cite&doi=10.46243%2Fjst.2021.v6.i2.pp17-22 gives all four in one JSON answer.
